Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype

Zholudev, Anna; Zurakowski, David; Young, Wes; Leichtner, Alan; Bousvaros, Athos
November 2004
American Journal of Gastroenterology;Nov2004, Vol. 99 Issue 11, p2235
Academic Journal
OBJECTIVES: Serologic testing is increasingly being utilized to evaluate children with suspected inflammatory bowel disease (IBD). The aim of this paper was to evaluate the sensitivity and specificity of a currently available panel involving four antibodies: deoxyribonuclease (DNase)-sensitive perinuclear antineutrophil cytoplasmic antibody (DNase-sensitive pANCA), lgA and lgG antibodies to Saccharomyces cerevisiae (lEA and lgG ASCA), and antibody to Escherichia coil outer membrane porin (anti-OmpC). We also wished to determine whether antibody levels correlated with disease activity, and whether a specific antibody pattern correlated with location and outcome of disease in children. METHODS: We studied sera from 81 children with Crohn's disease (CD), 54 with ulcerative colitis (UC), and 63 controls. Clinical data, disease activity, and disease diagnosis were gathered at the time of serum sampling, and charts were re-reviewed at time of the study to determine long-term outcome. Enzyme-linked immunosorbent assay was utilized to determine titers of antibodies to ASCA, DNase-sensitive pANCA, and anti-OmpC; the presence of perinuclear staining for ANCA was confirmed by immunofluorescence. RESULTS: We identified ASCA antibodies in 44% of CD patients, 0% of UC patients, and I control patient. DNase-sensitive pANCA antibodies were found in 70% of patients with UC, 18% of CD patients (predominantly Crohn's colitis), and 3% of controls. Anti-OmpC as an isolated assay had low sensitivity for both CD (24%) and UC (11%), and displayed a 5% false-positive rate. However, anti-OmpC did identify a small number of IBD patients not detected by the other assays. If any one or more of the four antibodies was positive, the overall sensitivity of the four antibody panel was 65% for CD and 76% for UC, with a specificity of 94%. Patients who were ASCA-positive were more likely to have disease of the ileum or ileum and right colon than patients who were ASCA-negative (58% vs 18%, p <0.001). Patients with ASCA-positive were also more likely to require ileocecal resection (36% vs 13%, p <0.05). CONCLUSIONS: A currently available commercial antibody panel has good sensitivity and excellent specificity for CD and UC. The ASCA antibodies, while highly specific for CD, identify predominantly the subset of children with disease of the ileum and ascending colon who may be at increased risk of surgery.


Related Articles

  • Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Halfvarson, J.; Standaert-Vitse, A.; Järnerot, G.; Sendid, B.; Jouoult, L.; Bodin, L.; Duhamel, A.; Colombel, J. F.; Tysk, C.; Poulain, D. // Gut;Sep2005, Vol. 54 Issue 9, p1237 

    Background and aims: An increased occurrence of anti-Saccharomyces cerevisiae antibodies (ASCA) is reported in unaffected members of families with Crohn's disease. Whether ASCA is a familial trait due to genetic factors or is caused by exposure to environmental factors is unknown. To assess the...

  • The role of red cell distribution width as a marker in inflammatory bowel disease. ARHAN, Mehmet; ÖNAL, İbrahim Koral; TAŞ, Adnan; KURT, Mevlüt; KALKAN, İsmail Hakkı; ÖZİN, Yasemin; TUNÇ, Bilge; ÜLKER, Aysel // Turkish Journal of Medical Sciences;Apr2011, Vol. 41 Issue 2, p227 

    No abstract available.

  • Familial Expression of Anti-Saccharomyces cerevisiae Mannan Antibodies in Crohn's Disease and Ulcerative Colitis: A GISC Study. Annese, V.; Anmdreoli, A.; Andriulli, A.; D'Inca, R.; Giochetti, P.; Latiano, A.; Lombardi, G.; Piepoli, A.; Poulain, D.; Sendid, B.; Colombardi, J. F. // American Journal of Gastroenterology;Aug2001, Vol. 96 Issue 8, p2407 

    OBJECTIVES: Recent studies in familial Crohn's disease (CD) have suggested that anti-Saccharomyces cerevisiae mannan antibodies (ASCAs) may represent a new specific marker of genetic susceptibility. In this study we aimed to assess the importance of ASCAs by comparing their presence in...

  • Higher Titers of Anti-Saccharomyces Cerevisiae Antibodies IgA and IgG are Associated with More Aggressive Phenotypes in Romanian Patients with Crohn's Disease. Gologan, Serban; Iacob, Razvan; Preda, Carmen; Vadan, Roxana; Cotruta, Bogdan; Catuneanu, Ana-Maria; Iacob, Speranta; Constantinescu, Ileana; Gheorghe, Liana; Iobagiu, Silviu; Gheorghe, Cristian; Diculescu, Mircea // Journal of Gastrointestinal & Liver Diseases;Mar2012, Vol. 21 Issue 1, p39 

    Background & Aims. Serological markers have been widely used for diagnostic purposes and disease stratification in inflammatory bowel diseases (IBD). The aim of this study was to investigate the seroprevalence and the correlations of anti-Saccharomyces cerevisiae antibodies (ASCA) titers with...

  • Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Autoantibodies in Inflammatory Bowel Disease. Peeters, Marc; Joossens, Sofie; Vermeire, Severine; Vlietinck, Robert; Bossuyt, Xavier; Rutgeerts, Paul // American Journal of Gastroenterology;Mar2001, Vol. 96 Issue 3, p730 

    OBJECTIVES: Correct diagnosis of inflammatory bowel disease (IBD), especially the differentiation between Crohn's disease (CD) and ulcerative colitis (UC), is highly important toward treatment and prognosis. Serological markers are noninvasive diagnostic tools that could be of value in...

  • Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Aydin, S. Z.; Atagunduz, P.; Temel, M.; Bicakcigil, M.; Tasan, D.; Direskeneli, H. // Rheumatology;Feb2008, Vol. 47 Issue 2, p142 

    Objectives. Seronegative spondyloarthropathies, especially ankylosing spondylitis (AS), is shown to be associated with inflammatory bowel disease. Anti-Saccharomyces cerevisiae antibodies (ASCA) is a valid serological marker for Crohn's disease. Presence of ASCA is controversial in AS. In this...

  • Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. Ghoshal, U. C.; Ghoshal, U.; Singh, H.; Tiwari, S. // Journal of Postgraduate Medicine;Jul-Sep2007, Vol. 53 Issue 3, p166 

    Context: Clinical, endoscopic, radiological and histological parameters of intestinal tuberculosis (IT) and Crohn.s disease (CD) are so similar that differentiation between these two diseases, which require different treatment, is difficult. Anti-Saccharomyces cerevisiae antibody (ASCA), which...

  • Anti- Saccharomyces cerevisiae Antibodies Associate with Phenotypes and Higher Risk for Surgery in Crohn's Disease: A Meta-Analysis. Zhang, Zhaoxia; Li, Chen; Zhao, Xinmei; Lv, Chaolan; He, Qiong; Lei, Shan; Guo, Yandong; Zhi, Fachao // Digestive Diseases & Sciences;Nov2012, Vol. 57 Issue 11, p2944 

    Background: Recent studies suggested that anti- Saccharomyces cerevisiae antibody (ASCA) status was associated with diagnostic findings, stratified classification phenotypes, disease activity and clinical course of Crohn's disease (CD). However, the relationship between ASCA status and...

  • Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease - a Longitudinal Analysis. Rieder, Florian; Lopez, Rocio; Franke, Andre; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Schirbel, Anja; Rosenstiel, Philip; Dotan, Nir; Schreiber, Stefan; Rogler, Gerhard; Klebl, Frank // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Introduction: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics